Skip to main content
. 2022 Mar 2;19:62. doi: 10.1186/s12974-022-02420-2

Table 2.

Location profile of NMOSD attacks

Location profile NMOSD–AQP4+ (N = 121) NMOSD–MOG+ (N = 67) NMOSD–DN (N = 23) Total (N = 211)
Isolated myelitis 66 (71.0%) 17 (18.3%) 10 (10.8%) 93 (44%)
Isolated optic neuritis 34 (46.6%) 35 (47.9%) 4 (5.5%) 73 (35%)
Isolated brainstem 5 (71.4%) 2 (28.6%) 0 (0%) 7 (3.3%)
Isolated encephalitis 0 (0%) 2 (100%) 0 (0%) 2 (0.9%)
Myelitis + optic neuritis (Neuromyelitis optica) 6 (37.5%) 5 (31.3%) 5 (31.3%) 16 (8%)
Optic neuritis + brainstem 0 (0%) 0 (0%) 1 (100%) 1 (0.5%)
Optic neuritis + encephalitis 0 (0%) 1 (100%) 0 (0%) 1 (0.5%)
Myelitis + encephalitis 1* (100%) 0 (0%) 0 (0%) 1 (0.5%)
Myelitis + brainstem 6 (54.5%) 4 (36.4%) 1 (9.1%) 11 (5.2%)
Myelitis + optic neuritis + brainstem 1 (25.0%) 1 (25.0%) 2 (50.0%) 4 (1.9%)
Myelitis + brainstem + encephalitis 1* (100%) 0 (0%) 0 (0%) 1 (0.5%)
Myelitis + optic neuritis + brainstem + encephalitis 1* (100%) 0 (0%) 0 (0%) 1 (0.5%)

Neuromyelitis optica spectrum disorder presentations and their serotypes. Nine attacks were multifocal, including 3 cases of NMOSD–AQP4+ acute demyelinating encephalomyelitis (*). Categorical variables are presented as count (percentage). Percentages are in the column axis for the “Total” column and in the row axis for the others

NMOSD–AQP4+: NMOSD attacks with anti-AQP4 antibodies; NMOSD–MOG+: NMOSD attacks with anti-MOG antibodies; NMOSD–DN: double seronegative NMOSD attacks